Health tech innovation has reached a climax over the last decade, and the leaders of the world’s increasingly complex healthcare ecosystems are ready to respond.
But significant hurdles remain, from value-alignment adoption, reimbursement, to effective collaboration between stakeholders – all challenges which the COVID-19 crisis has accentuated by accelerating healthcare’s digitalisation and demonstrating the need for well-connected healthcare ecosystems. A panel of innovation leaders across health systems, pharma, medical technology and investment, discuss the state of health tech innovation, where we’re headed, and the collaborations and realignments necessary to get us there.
What will be covered?
- Health tech innovation has reached a climax over the last decade - how are the leaders of the world’s increasingly complex healthcare ecosystems respond?
- Where are the hurdles holding back healthcare transformation, from value-alignment, adoption and reimbursement and sustainable commercial models?
- Where is healthcare headed and which collaborations and realignments will be necessary to get us there?
Jeroen Tas, Chief Innovation Officer, Philips
Moderator: Russ Johannesson, CEO, Glooko